The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis

Annals of Hematology

Volumn 88, Issue 1, 2009, Pages 73-76

  Eroglu, Aydan ^a   Egin, Yonca ^a   Çam, Ragip ^a   Akar, Nejat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cancer; DHFR; FVL; MTHFR; PTG20210; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; DIHYDROFOLATE REDUCTASE; GENOMIC DNA; PROTHROMBIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER PATIENT; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENOME SIZE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MUTATION RATE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOMA; THROMBOSIS; UROGENITAL TRACT CANCER; VENOUS THROMBOEMBOLISM;

FACTOR V; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEOPLASMS; POINT MUTATION; POLYMORPHISM, GENETIC; PROTHROMBIN; SEQUENCE DELETION; TETRAHYDROFOLATE DEHYDROGENASE; THROMBOSIS;

EID: 57049139443     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0569-6     Document Type: Article

References (15)

1. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504-1508
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 8:698-703
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG (1995) A candidate genetic inheritable thrombophilic defect for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
4. Ray JG, Shmorgun D, Chan WS (2002) Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: Meta-analysis of 31 studies. Pathophysiol Haemost Thromb 32:51-58
5. Naess IA, Chritiansen SC, Romundstad PR, Cannegieter SC, Blom HJ, Rosendaal FR, Hammerstrom J (2008) Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population-results from the HUNT 2 study. Br J Haematol 141: 529-535
6. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S (2004) New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet 124A:339-345
7. Gellekink H, Blom HJ, van der Linden IJM, den Heijer M (2007) Molecular genetic analysis of the human dihydrofolate reductase gene: Relation with plasma total homocysteine, serum and red blood cell folate levels. Eur J Hum Genet 15:103-109
8. Johnson WG, Scholl TO, Spychala JR, Buyske S, Stenroos ES, Chen X (2005) Common dihydrofolate reductase 19-base pair deletion allele: A novel risk factor for preterm delivery. Am J Clin Nutr 81:664-668
9. Parle-McDermott A, Pangilinan F, Mills JL, Kirke PN, Gibney ER, Troendle J, O'Leary VB, Molloy AM, Conley M, Scott JM, Brody LC. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population
10. Decousus H, Moulin N, Quenet S, Bost V, Rivron-Guillot K, Laporte S, Mismetti P (2007) Thrombophilia and risk of venous thrombosis in patients with cancer. Thromb Res 120(Suppl 2):S51-S61
11. Eroglu A, Ulu A, Cam R, Kurtman C, Akar N (2007) Prevalence of factor V 1691G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients. J Thromb Thrombolysis 23:31-34
12. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ (1998) Hyperhomocysteinemia and venous thrombosis: A meta-analysis. Thromb Haemost 80:874-877
13. Pihusch R, Danzl G, Scholz M, Harich D, Pihusch M, Lohse P (2002) Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Cancer 94:3120-3126
14. Ramacciotti E, Wolosker N, Peuch-Leao P, Zeratti EA, Gusson PR, del Giglio A, Franco RF (2003) Prvalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis. Thromb Res 109:171-174
15. Sciacca FL, Ciusani E, Silvani A, Corsini E, Frigerio S, Pogliani S, Parati E, Croci D, Boiardi A, Salmaggi A (2004) Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin Cancer Res 10:1312-1317